Rxo (RXO) Receivables - Other (2021 - 2025)
Rxo (RXO) has disclosed Receivables - Other for 5 consecutive years, with $26.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other rose 52.94% year-over-year to $26.0 million, compared with a TTM value of $26.0 million through Dec 2025, up 52.94%, and an annual FY2025 reading of $26.0 million, up 52.94% over the prior year.
- Receivables - Other was $26.0 million for Q4 2025 at Rxo, up from $17.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $26.0 million in Q4 2025 and bottomed at $5.0 million in Q3 2022.
- Average Receivables - Other over 5 years is $13.8 million, with a median of $11.0 million recorded in 2023.
- The sharpest move saw Receivables - Other soared 54.55% in 2024, then soared 52.94% in 2025.
- Year by year, Receivables - Other stood at $10.0 million in 2021, then crashed by 50.0% to $5.0 million in 2022, then soared by 120.0% to $11.0 million in 2023, then skyrocketed by 54.55% to $17.0 million in 2024, then surged by 52.94% to $26.0 million in 2025.
- Business Quant data shows Receivables - Other for RXO at $26.0 million in Q4 2025, $17.0 million in Q4 2024, and $11.0 million in Q4 2023.